Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ibrance
Ibrance
A slowing market—not new rivals—is hurting Pfizer's star cancer drug Ibrance, executives say
Fierce Pharma
Wed, 08/1/18 - 11:50 pm
Pfizer
Ibrance
breast cancer
Pfizer's breast cancer drug combo falls short of survival goal
Yahoo/Reuters
Mon, 06/25/18 - 12:42 pm
Pfizer
breast cancer
Ibrance
clinical trials
Merck gets a lift, Pfizer a ding as analysts assess immuno-oncology, M&A outlook
Fierce Pharma
Fri, 04/6/18 - 11:49 am
Merck
Pfizer
immuno-oncology
M&A
Keytruda
Prevnar
Ibrance
Xeljanz
Xtandi
Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica
Fierce Pharma
Sun, 03/25/18 - 11:18 am
Pfizer
Ibrance
television ads
Humira
AbbVie
DTC advertising
Lyrica
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
Mon, 02/26/18 - 11:30 am
drug launches
hepatitis C
Ibrance
Tecfidera
Biogen
Pfizer
Gilead Sciences
Pfizer's Q4 Earnings Preview: Watching Ibrance And Prevnar Sales
Forbes
Fri, 01/26/18 - 05:27 pm
Pfizer
earnings
Ibrance
Prevnar
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations
Fierce Pharma
Thu, 11/16/17 - 11:07 am
Pfizer
Ibrance
Novartis
Kisqali
England
breast cancer
UK
NICE
Novartis takes fight to Pfizer's Ibrance with new Kisqali data
Yahoo/Reuters
Wed, 11/8/17 - 10:10 am
Novartis
Pfizer
Ibrance
Kisqali
breast cancer
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Mon, 10/30/17 - 10:00 am
Verzenio
Ibrance
Kisqali
drug launches
breast cancer. Eli Lilly
Pfizer
Novartis
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval
Fierce Pharma
Thu, 09/28/17 - 06:24 pm
Eli Lilly
Pfizer
Novartis
Verzenio
breast cancer
Ibrance
Kisqali
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Fierce Pharma
Thu, 09/21/17 - 10:18 pm
Pfizer
Ibrance
breast cancer
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
Fierce Pharma
Thu, 08/24/17 - 05:11 pm
Novartis
Kisqali
Pfizer
Ibrance
reimbursement
breast cancer
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Yahoo/Zacks.com
Wed, 08/23/17 - 11:14 am
Pfizer
Ibrance
breast cancer
Faslodex
AstraZeneca
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
Fierce Pharma
Mon, 08/7/17 - 01:32 pm
Novartis
Kisqali
Pfizer
Ibrance
breast cancer
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Fierce Pharma
Tue, 07/11/17 - 09:56 am
Eli Lilly
Pfizer
Novartis
breast cancer
abemaciclib
Ibrance
Kisqali
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
Pfizer bows first Ibrance TV spot as Novartis revs up with rival breast cancer med Kisqali
Fierce Pharma
Wed, 05/24/17 - 10:37 am
Pfizer
Ibrance
Novartis
breast cancer
drug ads
ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say
Fierce Pharma
Thu, 05/18/17 - 08:00 pm
ASCO 2017
Eli Lilly
Pfizer
abemaciclib
Ibrance
breast cancer
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »